10 suspended. 10 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Suspended 10 |
| Phase 1 | 1 | Suspended 1 |
| Phase 3 | 1 | Suspended 1 |
Follow Pain: new trials by email Literature Review of Pain trials Research Report on Pain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of F14 Following Total Knee Replacement F14 (sustained release celecoxib) - Analgesia | Phase 2 / Phase 3 | Suspended | Arthritis Innovation Corporation | 100 | 2027-01-01 | 2026-06-05 |
| Reducing Opioid Use and Misuse After Wisdom Molar Extractions Twin block, iPill dispenser - Pain, Postoperative | Phase 2 | Suspended | Rutgers, The State University of New Jersey | 133 | 2026-11-01 | 2026-06-22 |
| Pain After Strabismus Surgery Tylenol - Strabismus | Phase 2 | Suspended | Ann & Robert H Lurie Children's Hospital of Chicago | 80 | 2026-10-01 | 2026-07-30 |
| Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer Resiniferatoxin, Placebo - Pain, Intractable, Pain Cancer | Phase 2 | Suspended | Sorrento Therapeutics, Inc. | 120 | 2025-09-01 | 2024-03-18 |
| Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy Ergocalciferol Capsules, Cholecalciferol Capsules - Neuropathic Pain | Phase 2 | Suspended | Virginia Commonwealth University | 120 | 2022-12-19 | 2026-05-14 |
| Impact of Repeatedly-Administered THC-cannabis on Experimental Pain and Abuse Liability in Humans Active Cannabis, Placebo Cannabis - Cannabis, Pain | Phase 2 | Suspended | New York State Psychiatric Institute | 16 | 2021-08-01 | 2026-09-24 |
| Evaluation of the Safety and Efficacy of N-desmethylclobazam in Patients With Peripheral Neuropathic Pain NDMC - Neuropathic Pain | Phase 2 | Suspended | Besson Marie | 76 | 2020-06-24 | 2023-05-10 |
| A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D) 0.075 mg RVX-100, 0.125 mg RVX-100, 0.250 mg RVX-100 - Irritable Bowel Syndrome | Phase 2 | Suspended | Revogenex, Inc. | 192 | 2010-03-01 | 2010-07-19 |
| High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain High intensity focused ultrasound, HIFU - Pain, Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | Suspended | CMED HIFU Development Corporation | 5 | 2008-03-01 | 2009-01-13 |
| Intramyocardial Delivery of Autologous Bone Marrow Mononuclear bone marrow derived cells - Refractory Angina | Phase 2 | Suspended | IRCCS San Raffaele | 13 | 2007-05-01 | 2012-02-02 |
Neuralgia (2) · Pain, Postoperative (2) · Abdominal Pain (1) · Agnosia (1) · Angina Pectoris (1) · Cancer Pain (1) · Diarrhea (1) · Hyperalgesia (1) · Irritable Bowel Syndrome (1) · Marijuana Abuse (1) · Pain, Intractable (1) · Pancreatic Neoplasms (1) · Strabismus (1)
Neurologic Manifestations (10) · Pathological Conditions, Signs and Symptoms (10) · Signs and Symptoms (10) · Nervous System Diseases (5) · Digestive System Diseases (2) · Neuromuscular Diseases (2) · Pathologic Processes (2) · Peripheral Nervous System Diseases (2) · Postoperative Complications (2) · Cardiovascular Diseases (1) · Chemically-Induced Disorders (1) · Chest Pain (1) · Colonic Diseases (1) · Colonic Diseases, Functional (1)
Acetaminophen (1) · Cholecalciferol (1) · Ergocalciferols (1) · Extracorporeal Shockwave Therapy (1) · Sugars (1) · resiniferatoxin (1)
Ann & Robert H Lurie Children's Hospital of Chicago (1) · Arthritis Innovation Corporation (1) · Besson Marie (1) · CMED HIFU Development Corporation (1) · IRCCS San Raffaele (1) · New York State Psychiatric Institute (1) · Revogenex, Inc. (1) · Rutgers, The State University of New Jersey (1) · Sorrento Therapeutics, Inc. (1) · Virginia Commonwealth University (1)
United States (8) · Italy (1) · Switzerland (1)
Anayo Adachie, DMD, MD (1) · Gayathri Subramanian, PhD DMD (1) · Jared Foran, MD (1) · Joo Ha Hwang, MD, PhD (1) · Marie Besson, MD (1) · Mike Royal, MD (1) · Robert Hardi, M.D., CPI (1) · Susan Hong, MD (1)
2019 (1), R21DA050752 (1)